332 related articles for article (PubMed ID: 10230180)
21. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
22. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
Bental B; Tirosh E
J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348
[TBL] [Abstract][Full Text] [Related]
23. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
[No Abstract] [Full Text] [Related]
24. Predicting methylphenidate response in children with ADHD: theoretical, empirical, and conceptual models.
Denney CB; Rapport MD
J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):393-401. PubMed ID: 10199110
[TBL] [Abstract][Full Text] [Related]
25. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
Olfson M; Marcus SC; Zhang HF; Wan GJ
J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749
[No Abstract] [Full Text] [Related]
26. [How to treat ADHD/DAMP? Is there a conclusive answer? A critical survey of the MTA trial?].
Hansen L; Thomsen PH
Ugeskr Laeger; 2005 Nov; 167(48):4555-9. PubMed ID: 16324436
[TBL] [Abstract][Full Text] [Related]
27. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.
Spencer T; Biederman J; Wilens T; Doyle R; Surman C; Prince J; Mick E; Aleardi M; Herzig K; Faraone S
Biol Psychiatry; 2005 Mar; 57(5):456-63. PubMed ID: 15737659
[TBL] [Abstract][Full Text] [Related]
28. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
29. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach.
DeSantis AD; Webb EM; Noar SM
J Am Coll Health; 2008; 57(3):315-24. PubMed ID: 18980888
[TBL] [Abstract][Full Text] [Related]
30. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children.
Swanson J; Gupta S; Guinta D; Flynn D; Agler D; Lerner M; Williams L; Shoulson I; Wigal S
Clin Pharmacol Ther; 1999 Sep; 66(3):295-305. PubMed ID: 10511066
[TBL] [Abstract][Full Text] [Related]
31. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
32. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
Harpin VA
Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
[TBL] [Abstract][Full Text] [Related]
33. The effect of methylphenidate on the cognitive and personality functioning of ADHD children.
Lufi D; Parish-Plass J; Gai E
Isr J Psychiatry Relat Sci; 1997; 34(3):200-9. PubMed ID: 9334525
[TBL] [Abstract][Full Text] [Related]
34. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder.
Barrickman LL; Perry PJ; Allen AJ; Kuperman S; Arndt SV; Herrmann KJ; Schumacher E
J Am Acad Child Adolesc Psychiatry; 1995 May; 34(5):649-57. PubMed ID: 7775360
[TBL] [Abstract][Full Text] [Related]
35. The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder.
Hawk LW; Yartz AR; Pelham WE; Lock TM
Psychopharmacology (Berl); 2003 Jan; 165(2):118-27. PubMed ID: 12417963
[TBL] [Abstract][Full Text] [Related]
36. Testing the ability of children with attention deficit hyperactivity disorder to accurately report the effects of medication on their behavior.
Ardoin SP; Martens BK
J Appl Behav Anal; 2000; 33(4):593-610. PubMed ID: 11214033
[TBL] [Abstract][Full Text] [Related]
37. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
[TBL] [Abstract][Full Text] [Related]
38. ADHD in girls: clinical comparability of a research sample.
Sharp WS; Walter JM; Marsh WL; Ritchie GF; Hamburger SD; Castellanos FX
J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):40-7. PubMed ID: 9893415
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.
Lurie S; O'Quinn A
J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171
[TBL] [Abstract][Full Text] [Related]
40. Clinical practice. Attention deficit-hyperactivity disorder.
Rappley MD
N Engl J Med; 2005 Jan; 352(2):165-73. PubMed ID: 15647579
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
